Austin Murata

Array ( [id] => 7280384 [patent_doc_number] => 20040062761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/120907 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 289877 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062761.pdf [firstpage_image] =>[orig_patent_app_number] => 10120907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439725 [patent_doc_number] => 07259236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof' [patent_app_type] => utility [patent_app_number] => 10/471934 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 21181 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259236.pdf [firstpage_image] =>[orig_patent_app_number] => 10471934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913545 [patent_doc_number] => 20060128607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Method for inhibiting \"melanoma inhibitory activity\" mia' [patent_app_type] => utility [patent_app_number] => 10/502771 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4429 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128607.pdf [firstpage_image] =>[orig_patent_app_number] => 10502771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432194 [patent_doc_number] => 07264967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding' [patent_app_type] => utility [patent_app_number] => 10/432236 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 28136 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264967.pdf [firstpage_image] =>[orig_patent_app_number] => 10432236 [rel_patent_id] =>[rel_patent_doc_number] =>)